B2A Stock Overview
Engages in the production and sale of organic and herbal products, natural cosmetics, and traditional food products in Italy. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Bioera S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.026 |
| 52 Week High | €0.11 |
| 52 Week Low | €0.001 |
| Beta | 1.12 |
| 11 Month Change | -51.30% |
| 3 Month Change | -50.00% |
| 1 Year Change | 249.33% |
| 33 Year Change | -97.48% |
| 5 Year Change | -99.61% |
| Change since IPO | -99.85% |
Recent News & Updates
Recent updates
Shareholder Returns
| B2A | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | -23.4% | 1.8% | 0.2% |
| 1Y | 249.3% | -6.0% | 8.5% |
Return vs Industry: B2A exceeded the German Personal Products industry which returned -6% over the past year.
Return vs Market: B2A exceeded the German Market which returned 8.5% over the past year.
Price Volatility
| B2A volatility | |
|---|---|
| B2A Average Weekly Movement | 24.0% |
| Personal Products Industry Average Movement | 3.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: B2A's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: B2A's weekly volatility has decreased from 51% to 24% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 4 | Giorgio Campeggio | www.bioera.it |
Bioera S.p.A. engages in the production and sale of organic and herbal products, natural cosmetics, and traditional food products in Italy. The company markets its products under the KI, Crudigno, and Fonte della Vita brand names; and distributes its products through outsourcers. The company was founded in 2004 and is headquartered in Milan, Italy.
Bioera S.p.A. Fundamentals Summary
| B2A fundamental statistics | |
|---|---|
| Market cap | €880.44k |
| Earnings (TTM) | -€6.20m |
| Revenue (TTM) | €1.15m |
0.8x
P/S Ratio-0.1x
P/E RatioIs B2A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| B2A income statement (TTM) | |
|---|---|
| Revenue | €1.15m |
| Cost of Revenue | €1.17m |
| Gross Profit | -€21.00k |
| Other Expenses | €6.18m |
| Earnings | -€6.20m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.30 |
| Gross Margin | -1.83% |
| Net Profit Margin | -539.39% |
| Debt/Equity Ratio | -57.5% |
How did B2A perform over the long term?
See historical performance and comparison